Exoskeleton Market Growth Drivers and Emerging Opportunities
Valued at USD 582.67 million in 2025, the exoskeleton market is projected to reach USD 665.26 million in 2026 and USD 1,953.42 million by 2034, growing at a CAGR of 14.39% during the forecast period 2026–2034. Polaris Market Research links this expansion to wider adoption of robotic rehabilitation equipment, a growing need for safety measures in the workplace and rising investment in assistive devices across healthcare, manufacturing, defense and logistics.
An exoskeleton is a mechanical device that improves, replaces and assists human movement using sensors, actuators, control systems and structural elements. For healthcare providers and device manufacturers, the Exoskeleton Market is increasingly defined by clinical outcomes, regulatory approvals and reimbursement conditions.
Rehabilitation Robotics Anchors Exoskeleton Market Demand
Rehabilitation robotics is the dominant application, holding a 45.80% share in 2025 as demand grows for neurological and orthopedic recovery solutions. Hospitals and rehabilitation centers use robotic systems to improve patient mobility and speed recovery, and hospitals held the largest end-user share at 51.40%. In June 2026, ETH Zurich introduced the AI-based MAYO Suit to ease walking for older adults and people with mobility issues. In November 2025, the US FDA broadened approval of Wandercraft's Atalante X to cover rehabilitation of people with multiple sclerosis and high-level spinal cord injuries.
Neurological Rehabilitation Expands the Clinical Opportunity
Growing numbers of patients recovering from stroke, spinal cord injuries and neurological disorders are accelerating investment in neurological rehabilitation. In June 2026, Northwestern University developed a robotic exoskeleton therapy system to improve gait rehabilitation and walking recovery for stroke survivors. In South Korea, Severance Hospital launched a government-supported initiative in June 2026 to develop brain-controlled wearable devices for quadriplegics. In December 2025, Verita Neuro and Lifeward added the ReWalk Personal Robotic Exoskeleton to a spinal cord injury program in the UAE.
Browse Insights:
https://www.polarismarketresearch.com/industry-analysis/exoskeleton-market
Mobile Exoskeletons Lead While Powered Exoskeletons Advance
Mobile exoskeletons accounted for the largest mobility segment with a 62.30% share in 2025, owing to broad use across rehabilitation, industrial and defense applications. They give users more flexibility in daily activities with less physical exertion, and improvements in battery technology and lighter materials are supporting growth. Powered exoskeletons are gaining traction as manufacturers add intelligent control systems and ergonomic design, while Polaris identifies stationary systems as the fastest-growing mobility segment. Medical exoskeletons are also benefiting from government funding for rehabilitation programs and the needs of an aging population.
Technology, Regulation and Cost Considerations
AI-driven real-time motion assistance improves movement accuracy, while motion sensors enable precise movement detection that improves rehabilitation outcomes and IoT connectivity allows remote monitoring. Regulation shapes adoption: the US FDA medical device framework and veterans rehabilitation programs support commercialization and clinical adoption, EU MDR supports product quality and patient safety in Germany, and Japan's Society 5.0 program accelerates rehabilitation robotics adoption. Polaris cost benchmarking places rehabilitation exoskeletons at USD 40,000–120,000, driven by medical-grade robotics, and healthcare providers focus on clinical performance and patient outcomes over a one-to-three-year procurement horizon.
Regional Outlook and Key Players
North America dominated in 2025 with a 40.50% share, supported by robotic rehabilitation adoption and favorable reimbursement initiatives. Asia Pacific is projected to grow at the fastest CAGR, led by investment in robotics, healthcare infrastructure and smart manufacturing in China, Japan, South Korea and India. The Exoskeleton is moderately fragmented. Key players include CYBERDYNE Inc., Ekso Bionics Holdings, Inc., German Bionic Systems GmbH, Honda Motor Co., Ltd., Lockheed Martin Corporation, Ottobock SE & Co. KGaA, Parker Hannifin Corporation, ReWalk Robotics Ltd., Sarcos Technology and Robotics Corporation, SUITX, Wandercraft SAS and Wearable Robotics Srl.
High product pricing and limited reimbursement remain the principal restraints, particularly in emerging markets, while AI and battery advances continue to create opportunities.
More Trending Latest Reports By Polaris Market Research:
Human Machine Interface (HMI) Market
Wearable Medical Device Market
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Giochi
- Gardening
- Health
- Home
- Literature
- Music
- Networking
- Altre informazioni
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness
- News
- Help Post